Nonsmall-cell lung cancer(NSCLC)
Showing 1 - 25 of >10,000
Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically
Recruiting
- Nonsmall Cell Lung Cancer
- +3 more
- Genomically Guided Radiation Therapy (RT)
-
Tampa, FloridaMoffitt Cancer Center
May 23, 2023
Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Lung Cancer Stage III
- Nivolumab and Chemotherapy
- +3 more
- (no location specified)
Aug 15, 2023
Non-Small Cell Lung Carcinoma Trial (Capmatinib 150 mg, Capmatinib 200 mg)
Recruiting
- Non-Small Cell Lung Carcinoma
- Capmatinib 150 mg
- Capmatinib 200 mg
-
Guwahati, Assam, India
- +7 more
Dec 19, 2022
NSCLC Trial in China (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)
Active, not recruiting
- Non-small Cell Lung Cancer
- Pembrolizumab
- +2 more
-
Hefei, Anhui, China
- +16 more
Oct 14, 2022
ICIs Combined With Chemotherapy in Advanced NSCLC
Recruiting
- Lung Cancer, Nonsmall Cell
-
Nanjing, Jiangsu, ChinaShuhua Han
Feb 10, 2023
NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 3, 2023
Lung Cancer, Nonsmall Cell Trial in Sacramento ([18F]F-AraG Imaging)
Enrolling by invitation
- Lung Cancer, Nonsmall Cell
- [18F]F-AraG Imaging
-
Sacramento, CaliforniaUC Davis EXPLORER Molecular Imaging Center
Jan 4, 2023
Non Small Cell Lung Cancer, NSCLC Trial in Saint Louis (CoreDx Pulmonary Mini-Forceps)
Completed
- Non Small Cell Lung Cancer
- NSCLC
- CoreDx Pulmonary Mini-Forceps
-
Saint Louis, MissouriWashington University School of Medicine
Feb 25, 2022
Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- +2 more
- SLC-391
- Pembrolizumab
-
Indianapolis, Indiana
- +8 more
May 5, 2023
Nonsmall Cell Lung Cancer Trial in Goyang-Si (Lorlatinib)
Recruiting
- Nonsmall Cell Lung Cancer
-
Goyang-Si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Apr 4, 2022
Nonsmall Cell Lung Cancer Trial in New York (Durvalumab, Tremelimumab)
Not yet recruiting
- Nonsmall Cell Lung Cancer
-
New York, New YorkColumbia University Irving Medical Center
Apr 29, 2022
Observes Afatinib as First-line Treatment and Sequential Therapy
Active, not recruiting
- Non-squamous, Non-Small Cell Lung Cancer
-
Beijing, China
- +9 more
Jan 9, 2023
Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
Recruiting
- Lung Neoplasms
- +3 more
- Observation
-
Shanghai, ChinaShanghai Chest Hospital
Mar 14, 2022
Lung Cancer, Nonsmall Cell Trial in United Kingdom (Pembrolizumab 25 MG/ML [Keytruda])
Recruiting
- Lung Cancer, Nonsmall Cell
- Pembrolizumab 25 MG/ML [Keytruda]
-
Manchester, United Kingdom
- +3 more
Aug 4, 2022
Nonsmall Cell Lung Cancer Trial in Anaheim, Beverly Hills, Aurora (HS-10296)
Active, not recruiting
- Nonsmall Cell Lung Cancer
-
Anaheim, California
- +9 more
Dec 27, 2022
Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer Trial in France, Switzerland, United Kingdom (1.0% IP-001 for
Recruiting
- Metastatic Solid Tumor
- +3 more
- 1.0% IP-001 for Injection
-
Bordeaux, France
- +9 more
Jan 26, 2023
NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- efineptakin alfa
- Atezolizumab
-
Mobile, Alabama
- +14 more
May 12, 2022
Lung Cancer, Nonsmall Cell Trial (Pembrolizumab, Carboplatin, Paclitaxel)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Pembrolizumab
- +3 more
- (no location specified)
May 7, 2021
Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma Trial in Winston-Salem (drug, other, diagnostic
Not yet recruiting
- Nonsmall Cell Lung Cancer Stage III
- Unresectable Non-Small Cell Lung Carcinoma
- Durvalumab
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 12, 2023
Nonsmall Cell Lung Cancer Trial in Fuzhou (Apatinib/docetaxel/pemetrexed, docetaxel/pemetrexed)
Terminated
- Nonsmall Cell Lung Cancer
-
Fuzhou, Fujian, ChinaFuzhou general hospital
Feb 3, 2021
Lung Cancer, Nonsmall Cell, Lung Cancer Stage I, Lung Cancer Stage II Trial in Columbia (Breathe Easier Progressive Web
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- +3 more
- Breathe Easier Progressive Web Application
-
Columbia, South CarolinaUniversity of South Carolina
Sep 22, 2023
Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Port Saint Lucie, Florida
- +1 more
Aug 11, 2023
Lung Cancer, Nonsmall Cell, Quality of Life, Physical Disability Trial in Rio De Janeiro (ADL-Glittre Test)
Enrolling by invitation
- Lung Cancer, Nonsmall Cell
- +3 more
- ADL-Glittre Test
-
Rio De Janeiro, BrazilCentro Universitário Augusto Motta
May 8, 2023